Not true.. you have said via multiple posts that the product is flawed and no pharma would be interested..which insinuates Nina is lying to the market about partner discussions and the legitimacy of the trial.
Ann: Notification of upcoming expiry of Unlisted Options, page-62
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.3¢ |
Change
0.008(1.69%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 45.3¢ | 43.0¢ | $174.4K | 397.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 51685 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 129763 | 7 |
View Market Depth
| Last trade - 12.33pm 20/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |